stock pickVTGNemail_stock_pick
VTGN: Urgent Action Needed for Investors Facing Losses!
# VTGN: Urgent Action Needed for Investors Facing Losses!
Read moreFeatured By
Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# VTGN: Urgent Action Needed for Investors Facing Losses!
Read more# **MREO Alert: Class Action Deadline Approaches April 6, 2026!** ## **Company Overview** Mereo BioPharma Group plc (NASDAQ: MREO) is a UK-based clinical-stage biopharmaceutical…
Read moreFranklin Universal Trust (FT) Overview Franklin Universal Trust (ticker FT) is a closed-end fund managed by Franklin Templeton, with a strategy of investing in a mix of high-yield…
Read more# Is PDD Holdings (PDD) Zhang Lei’s Top Pick? Find Out Now! ## Introduction PDD Holdings Inc.
Read more# Is MU the Next Nvidia or Intel? Find Out Now!
Read more# What Analysts Are Predicting for BMY—Don't Miss Out! ## Introduction Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company known for blockbuster drugs in…
Read more# VTGN Investors Alert: Secure Counsel Before Deadline!
Read more# CHRS: Don’t Miss Coherus’ New Stock Offering Opportunity! ## Overview – A Strategic Shift and Recent Offering Coherus Oncology, Inc. (NASDAQ: **CHRS**) – formerly Coherus…
Read more# MREO Alert: Class Action Deadline Approaches April 6, 2026!
Read more# SEI: Savy King Returns—A Game-Changer for Solaris! ## Business Overview & Leadership Moves Solaris Energy Infrastructure, Inc. (NYSE: **SEI**), formerly Solaris Oilfield…
Read more# C: Aardvark Grants Boost Citigroup's Nasdaq Prospects! ## Introduction Citigroup Inc. (NYSE: C) is a global banking giant undergoing a significant transformation under CEO Jane…
Read more# PLTR’s AIP Growth Sparks Rare Double Upgrade! ## Introduction: AIP Supercharges Sentiment Palantir Technologies (NYSE: PLTR) – a data analytics and AI software firm – has…
Read more# WMT: Jim Cramer Calls Walmart a Great American Company!
Read more# MRK Gains FDA Approval for KEYTRUDA®—Big Opportunity! ## Keytruda’s New Approval and Business Overview Merck & Co.
Read more# IRON: FDA's Response Could Shift EPP Treatment Landscape! ## Company Overview and EPP Background Disc Medicine, Inc.
Read more# EBS: FDA Approves NARCAN® Multipacks—Act Now! ## Overview Emergent BioSolutions (NYSE: **EBS**) is a specialty biopharma company focused on public health threats and…
Read more# Citigroup (C): Next Move After Orchestra BioMed’s “Grant” – What’s Ahead? ## Company Overview and Context Citigroup Inc. (NYSE: C) is one of the world’s largest banks, with a…
Read more# NGEN: CFO Retirement Sparks New Strategic Opportunities! ## Company Overview and CFO Transition NervGen Pharma Corp.
Read more# VTGN Investors: Class Action Info for Major Losses!
Read more# EDSA’s 1Q 2026 Results: What You Need to Know Now! ## Company Overview & 1Q 2026 Highlights **Edesa Biotech (NASDAQ: EDSA)** is a clinical-stage biotech focused on…
Read more